Cargando…

THU447 Hungry Bone Syndrome Secondary To Denosumab Use In A Patient With Sleeve Gastrectomy

Disclosure: A. Prabha Kumar: None. M. Shakir: None. B. Sharma: None. O. Syed: None. S. Natarajan: None. M. Dominic: None. Our patient is a 60-year-old woman with significant past medical history of morbid obesity, requiring laparoscopic sleeve gastrectomy, converted to Single Anastomosis Duodeno-Ile...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Arathi Prabha, Shakir, Muhammad Hassan, Sharma, Brihant, Syed, Omar, Natarajan, Sarasija, Dominic, Maria Rose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Bone And Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554781/ http://dx.doi.org/10.1210/jendso/bvad114.408

Ejemplares similares

THU448 Multiple Non-traumatic Vertebral Fractures After Discontinuation Of Denosumab
por: Riahi, Shayan, et al.
Publicado: (2023)

THU445 Complicated Course And Management After Denosumab Discontinuation: A Case Report
por: Arora, Ipsa, et al.
Publicado: (2023)

Calciphylaxis in Association With Hungry Bone Syndrome. A Possible Risk Factor?
por: Arreaza, Javier, et al.
Publicado: (2021)

ODP117 Pseudohypoparathyroidism Type IB: A Rare Cause of Hypocalcemia
por: Encarnacion, Dionardo Medina, et al.
Publicado: (2022)

SAT-513 Cut To The Bone: Hypocalcemia From Hungry Bone Syndrome In A Dialysis Patient
por: Ghaith, Sarah, et al.
Publicado: (2019)

SAT-LB086 Hungry Bone Syndrome Post Thyroidectomy in a Patient with Uncontrolled Grave Disease
por: Gurnurkar, Shilpa, et al.
Publicado: (2019)

THU426 Randomized Controlled Trial Comparing The Efficacy Of Teriparatide, Zoledronate And Denosumab In Postmenopausal Women With Type 2 Diabetes Mellitus At High Risk Of Fragility Fractures: 6-month Interim Analysis Of HR-pQCT Parameters
por: Pal, Rimesh, et al.
Publicado: (2023)

SAT-499 Denosumab for Treatment of Hypercalcemia in Myelofibrosis
por: Wong, Beatrice, et al.
Publicado: (2019)

MON-356 Atypical Femur Fracture with Denosumab
por: Mirza, Faryal S, et al.
Publicado: (2020)

ODP085 Denosumab Induced Severe Hypophosphatemia
por: Del Mar Morales Hernandez, Maria, et al.
Publicado: (2022)

Secondary Hyperparathyroidism, Bone Density and Bone Turnover After Bariatric Surgery: Differences Between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
por: Holanda, Narriane Chaves Pereira, et al.
Publicado: (2021)

SUN-LB085 Complicated Hungry Bone Syndrome Due to Tertiary Hyperparathyroidism in a Patient with Kidney Transplant: A Case to Remember
por: Jimenez-Zuluaga, Jose, et al.
Publicado: (2019)

SAT-509 Denosumab Use in Tertiary Hiperparathyroidism with Fracture
por: Coy, Andres, et al.
Publicado: (2019)

OR13-06 Romosozumab After Denosumab Improves Lumbar Spine Bone Mineral Density And Microarchitecture Greater Than Denosumab Continuation In Postmenopausal Women
por: Hong, Namki, et al.
Publicado: (2023)

THU438 A Case Of Pregnancy Associated Osteoporosis
por: Maradana, Sandhya, et al.
Publicado: (2023)

THU422 Laboratory Evaluation For Etiologies Of Secondary Osteoporosis
por: Shah, Nandi, et al.
Publicado: (2023)

Severe Refractory Hypocalcemia After Administering Zoledronic Acid for Osteoporotic Fracture in Primary Hyperparathyroidism That Is Complicated Into Hungry Bone Syndrome: A Case Report
por: Alhamdan, Ali Saleh, et al.
Publicado: (2021)

SUN-391 Denosumab Treatment of Patients with Osteoporosis and Idiopathic Hypercalciuria
por: Chu, Winston S, et al.
Publicado: (2020)

Denosumab Induced Severe Prolonged Hypocalcemia in Metastatic Prostate Cancer
por: Mehmood, Hassan, et al.
Publicado: (2021)

Rebound Hypercalcemia After Denosumab Therapy in a Child With Cherubism
por: Litao, Melissa Kaori S, et al.
Publicado: (2021)

THU443 Acute Iridocyclitis Associated With Intravenous Zoledronic Acid
por: Ankireddypalli, Anvitha Reddy, et al.
Publicado: (2023)

THU464 An Uncommon Case Of Adult-Onset Hypophosphatemic Osteomalacia
por: Lockhart, Paola M, et al.
Publicado: (2023)

THU454 Paget’s Disease Of Bone As An Atypical Cause Of Headaches
por: Delgado Nieves, Andrea Nicole, et al.
Publicado: (2023)

THU433 Spontaneous Vertebral Fractures In The Setting Of Prolonged CRRT
por: Akanbi, Folake, et al.
Publicado: (2023)

THU468 Finding An Effective Treatment For Osteoporosis In Gaucher Disease
por: Lesniak, Christopher, et al.
Publicado: (2023)

THU437 Oral Ulcers As A Clue To Bone Fragility
por: Sridhar, Sushrutha, et al.
Publicado: (2023)

MON-517 Treatment of Gorham-Stout Disease with Combination Sirolimus and Denosumab
por: Hartley, Iris, et al.
Publicado: (2019)

SUN-513 Parathyromatosis: A Case of Stubborn Hypercalcemia Treated with Denosumab
por: Ventura, Kenilia, et al.
Publicado: (2019)

Denosumab Induced Severe Hypocalcemia in a Patient With Metastatic Prostate Cancer
por: Naher, Kamrun, et al.
Publicado: (2021)

THU441 Teriparatide As Treatment For Severe Osteoporosis In Lung Transplant Recipients
por: Muir, Christopher Alan, et al.
Publicado: (2023)

THU457 Variable Presentations Of Hypophosphatasia In Two Patients In The Outpatient Setting
por: Elmaaz, Ahmed, et al.
Publicado: (2023)

THU431 An Interesting Case Of Severe Osteoporosis In A Young Male
por: Bilbatua, Martha, et al.
Publicado: (2023)

THU415 Trabecular Bone Score In Hospitalized Patients With Heart Failure
por: Bandeira, Francisco, et al.
Publicado: (2023)

THU404 Classical Symptoms Masquerading As A Surprising Clinical Picture
por: Syal, Arshi, et al.
Publicado: (2023)

THU412 Role of Glucocorticoid On Bone Metabolism Through AKAP13
por: Igarashi, Katsushi, et al.
Publicado: (2023)

THU467 Pharmacokinetics And Pharmacodynamics Of Garetosmab In Patients With Fibrodysplasia Ossificans Progressiva
por: Wang, Yuhuan, et al.
Publicado: (2023)

THU406 24-hydroxylase Deficiency, A Rare Cause Of Hypercalcemia
por: Hodge, Jordesha, et al.
Publicado: (2023)

SAT-532 Bisphosphonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation
por: Zanchetta, Maria Belen, et al.
Publicado: (2019)

SUN-514 Severe Hypophosphatemia and Worsening Secondary Hyperparathyroidism Following Treatment with Denosumab
por: Adepoju, Yewande, et al.
Publicado: (2019)

MON-335 Bisphosphonate and Denosumab Refractory Hypercalcemia of Malignancy: What Else Is at Play?
por: Patel, Reshma, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tjprfqa2jm6rnj3c4md5vvi3i5